Goldman Sachs
KURA icon

Goldman Sachs’s Kura Oncology KURA Stock Holding History

Goldman Sachs’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-70,000
Closed -$2.29M – 6220
2020
Q4 		$2.29M Buy
+70,000
New +$2.46M ﹤0.01% 3629

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs's KURA Position: Q1 2026 in Review

Goldman Sachs reduced its Kura Oncology (KURA) stake by 22% in Q1 2026, selling an estimated $3.47M and leaving 1,433,471 shares worth $11.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2937.

Goldman Sachs first reported a position in KURA in Q1 2016 and has held it in 38 quarters since. The position peaked at $41M in Q4 2020. 220 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • Goldman Sachs held 1,433,471 shares of Kura Oncology worth $11.7M as of Q1 2026.
  • Goldman Sachs sold 403,793 Kura Oncology shares in Q1 2026, an estimated $3.47M.
  • Kura Oncology made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #2937 holding.
  • Goldman Sachs first reported a position in Kura Oncology in Q1 2016 and has held it in 38 quarters since.
  • Goldman Sachs's Kura Oncology position peaked at $41M in Q4 2020.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.